These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2275208)

  • 1. [Current cellular aspects of atherosclerosis. Risk factors in its etiology and treatment].
    Schettler G
    Wien Med Wochenschr; 1990; 140(21):530-1. PubMed ID: 2275208
    [No Abstract]   [Full Text] [Related]  

  • 2. The hidden effects of antihypertensive and lipid-lowering agents on the prevention and regression of atherogenesis: new management strategies.
    Weinberg MS
    R I Med; 1995 Mar; 78(3):78-81. PubMed ID: 7734758
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing risk factors for atherosclerosis in critical limb ischaemia.
    Gottsäter A
    Eur J Vasc Endovasc Surg; 2006 Nov; 32(5):478-83. PubMed ID: 16631394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes is not treated as a coronary artery disease risk equivalent.
    Shah BR; Hux JE; Austin PC
    Diabetes Care; 2007 Feb; 30(2):381-3. PubMed ID: 17259516
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial on CHD.
    Riesen WF
    J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S1-2. PubMed ID: 9044998
    [No Abstract]   [Full Text] [Related]  

  • 6. The science behind statins and fibrates.
    Fruchart JC
    Int J Clin Pract Suppl; 2002 Oct; (132):11-6. PubMed ID: 12425358
    [No Abstract]   [Full Text] [Related]  

  • 7. The critical role of the endothelial cell in acute coronary events.
    Futterman LG; Lemberg L
    Am J Crit Care; 2001 May; 10(3):191-9. PubMed ID: 11340742
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipid-lowering agents and their meaning in the treatment of the fat metabolism-atherosclerosis functional circle.
    Kuemmerle HP
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):289-96. PubMed ID: 7263106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atherosclerosis and simvastatin: new questions for the new millennium].
    Tubaro M; Guido V; Sciarra L; Mustilli M; Carbone MA; D'Errico F
    Ann Ital Med Int; 2000; 15(1):108-14. PubMed ID: 10842900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [What other effects do statins have except their effect on lipids?].
    Tikkanen MJ
    Duodecim; 1998; 114(13):1299-301. PubMed ID: 11552256
    [No Abstract]   [Full Text] [Related]  

  • 11. Trials and tribulations.
    Packard CJ
    Int J Clin Pract Suppl; 2002 Oct; (132):3-10. PubMed ID: 12425357
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lipid lowering treatment of patients with atherosclerotic disease of the lower extremities].
    Bismuth J; Kofoed SC; Sillesen HH
    Ugeskr Laeger; 2001 Dec; 163(49):6882-5. PubMed ID: 11766498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug treatment of hypercholesterolaemia. Determine cardiac risk.
    Capps N; Hartland A
    BMJ; 1994 Jan; 308(6920):56-7. PubMed ID: 8298358
    [No Abstract]   [Full Text] [Related]  

  • 14. [New developments in the prevention and treatment of atherosclerosis, ischemic heart disease, hyperlipidemia and other diseases].
    Samsonov MA; Isaev VA
    Vopr Pitan; 1995; (4):33-4. PubMed ID: 7483479
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diabetics' life is about one third shorter. So you improve the prognosis of these high-risk patients].
    Stiefelhagen P
    MMW Fortschr Med; 2003 Apr; 145(15):18, 20. PubMed ID: 15104261
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathogenic mechanisms of atherosclerosis: effect of lipid lowering on the biology of atherosclerosis.
    Ganz P; Creager MA; Fang JC; McConnell MV; Lee RT; Libby P; Selwyn AP
    Am J Med; 1996 Oct; 101(4A):4A10S-16S. PubMed ID: 8900332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipids and their role in coronary heart disease: what they do and how to manage them.
    Pradka LR
    Nurs Clin North Am; 2000 Dec; 35(4):981-91. PubMed ID: 11072283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.
    ; ; ; ; ;
    Heart; 2005 Dec; 91 Suppl 5(Suppl 5):v1-52. PubMed ID: 16365341
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel insights on high-density lipoprotein in coronary heart disease.
    Genest J
    Int J Clin Pract Suppl; 2002 Oct; (132):17-22. PubMed ID: 12425359
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current treatment of the hyperlipoproteinemias. Risk factor for coronary disease].
    Gutiérrez Fuentes JA; Gutiérrez Yago JJ; Díez Monedero E
    Med Clin (Barc); 1987 Jul; 89(6):253-7. PubMed ID: 3626690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.